These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6121790)

  • 21. Management of conventional antipsychotic-induced tardive dyskinesia.
    Margolese HC; Ferreri F
    J Psychiatry Neurosci; 2007 Jan; 32(1):72. PubMed ID: 17245473
    [No Abstract]   [Full Text] [Related]  

  • 22. Attenuation of neuroleptic-induced extrapyramidal side effects by Kava special extract WS 1490.
    Boerner RJ; Klement S
    Wien Med Wochenschr; 2004 Nov; 154(21-22):508-10. PubMed ID: 15638068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pro- and antioxidant processes in schizophrenics with tardive dyskinesia].
    Gałecki P; Pietras T; Florkowki A
    Psychiatr Pol; 2005; 39(6):1131-41. PubMed ID: 16526180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible enhancing effects of diazepam with reserpine in a chronic schizophrenic patient with tardive dyskinesia.
    Bacher NM; Field PB; Elkashef A
    J Clin Psychopharmacol; 1989 Aug; 9(4):312. PubMed ID: 2570090
    [No Abstract]   [Full Text] [Related]  

  • 26. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of carbamazepine against neuroleptic-induced akathisia in treatment with perospirone: case series.
    Masui T; Kusumi I; Takahashi Y; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):343-6. PubMed ID: 15694245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of tardive akathisia.
    Sachdev P; Chee KY
    Biol Psychiatry; 1990 Nov; 28(9):809-18. PubMed ID: 1979500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic trial of gamma-vinyl GABA, an inhibitor of GABA transaminase, in tardive dyskinesias induced by neuroleptics].
    Lambert PA; Cantiniaux P; Chabannes JP; Tell GP; Schechter PJ; Koch-Weser J
    Encephale; 1982; 8(3):371-6. PubMed ID: 6137357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of benzodiazepines in schizophrenic psychoses].
    Colonna L; Zann M
    Encephale; 1983; 9(4 Suppl 2):279B-285B. PubMed ID: 6144525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine-induced tardive dyskinesia: a case report.
    Ertugrul A; Demir B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):633-5. PubMed ID: 15866369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tardive dyskinesia with schizophrenic relapse.
    Jawed SH; Singh I
    J Ment Defic Res; 1989 Aug; 33 ( Pt 4)():331-4. PubMed ID: 2570160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tardive dystonia: a rare side effect after long-term neuroleptic treatment].
    Bartels M; Riffel B; Stöhr M
    Nervenarzt; 1982 Nov; 53(11):674-6. PubMed ID: 6129578
    [No Abstract]   [Full Text] [Related]  

  • 35. Buspirone in the treatment of tardive dyskinesia.
    Moss LE; Neppe VM; Drevets WC
    J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Benzodiazepine monotherapy in acute schizophrenia].
    Jaspert A; Ebert D
    Nervenarzt; 1994 Jan; 65(1):62-5. PubMed ID: 7908419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noncompliance with antiparkinsonian medications in neuroleptic-treated schizophrenic patients: three cases of an unreported phenomenon.
    Bermanzohn PC; Siris SG
    J Clin Psychiatry; 1994 Nov; 55(11):488-91. PubMed ID: 7989282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of gabaergic drugs on reserpine-induced oral dyskinesia.
    Peixoto MF; Araujo NP; Silva RH; Castro JP; Fukushiro DF; Faria RR; Zanier-Gomes PH; Medrano WA; Frussa-Filho R; Abílio VC
    Behav Brain Res; 2005 May; 160(1):51-9. PubMed ID: 15836900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of tardive dyskinesia with risperidone: a case report.
    Kooptiwoot S; Settachan T
    J Med Assoc Thai; 2000 Nov; 83(11):1430-2. PubMed ID: 11215878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.